Cieza A, Causey K, Kamenov K, Hanson SW, Chatterji S, Vos T. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2021;396:2006–17. https://doi.org/10.1016/S0140-6736(20)32340-0.

Article  PubMed  Google Scholar 

Driscoll T, Jacklyn G, Orchard J, Passmore E, Vos T, Freedman G, et al. The global burden of occupationally related low back pain: estimates from the global burden of Disease 2010 study. Ann Rheum Dis. 2014;73:975–81. https://doi.org/10.1136/annrheumdis-2013-204631.

Article  CAS  PubMed  Google Scholar 

Mohd Isa IL, Teoh SL, Nor M, N. H., and, Mokhtar SA. Discogenic low back Pain: anatomy, pathophysiology and treatments of intervertebral disc degeneration. Int J Mol Sci. 2022;24. https://doi.org/10.3390/ijms24010208.

Desmoulin GT, Pradhan V, Milner TE. Mechanical aspects of intervertebral disc Injury and implications on Biomechanics. Spine. 2020;45:E457–64. https://doi.org/10.1097/BRS.0000000000003291.

Article  PubMed  Google Scholar 

Mayer JE, Iatridis JC, Chan D, Qureshi SA, Gottesman O, Hecht AC. Genetic polymorphisms associated with intervertebral disc degeneration. Spine J. 2013;13:299–317. https://doi.org/10.1016/j.spinee.2013.01.041.

Article  PubMed  PubMed Central  Google Scholar 

Vieira LA, Dos Santos AA, Peluso C, Barbosa CP, Bianco B, Rodrigues L. Influence of lifestyle characteristics and VDR polymorphisms as risk factors for intervertebral disc degeneration: a case-control study. Eur J Med Res. 2018;23:11. https://doi.org/10.1186/s40001-018-0309-x.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S. The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother. 2020;131:110660. https://doi.org/10.1016/j.biopha.2020.110660.

Article  CAS  PubMed  Google Scholar 

Zhao K, An R, Xiang Q, Li G, Wang K, Song Y, et al. Acid-sensing ion channels regulate nucleus pulposus cell inflammation and pyroptosis via the NLRP3 inflammasome in intervertebral disc degeneration. Cell Prolif. 2021;54:e12941. https://doi.org/10.1111/cpr.12941.

Article  CAS  PubMed  Google Scholar 

Zhang GZ, Liu MQ, Chen HW, Wu ZL, Gao YC, Ma ZJ, et al. NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. Cell Prolif. 2021;54:e13057. https://doi.org/10.1111/cpr.13057.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang HJ, Liao HY, Bai DY, Wang ZQ, Xie XW. MAPK /ERK signaling pathway: a potential target for the treatment of intervertebral disc degeneration. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2021;143:112170. https://doi.org/10.1016/j.biopha.2021.112170.

Article  CAS  PubMed  Google Scholar 

Hu X, Zhang K, Pan G, Wang Y, Shen Y, Peng C, et al. Cortex Mori extracts induce apoptosis and inhibit tumor invasion via blockage of the PI3K/AKT signaling in melanoma cells. Front Pharmacol. 2022;13:1007279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma LL, Yuan YY, Zhao M, Zhou XR, Jehangir T, Wang FY, et al. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats. Chin J Nat Med. 2018;16(6):411–7.

CAS  PubMed  Google Scholar 

Wang CP, Zhang LZ, Li GC, Shi YW, Li JL, Zhang XC, et al. Mulberroside A protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion. J Neurosci Res. 2014;92:944–54. https://doi.org/10.1002/jnr.23374.

Article  CAS  PubMed  Google Scholar 

Wang CP, Wang Y, Wang X, Zhang X, Ye JF, Hu LS, et al. Mulberroside a possesses potent uricosuric and nephroprotective effects in hyperuricemic mice. Planta Med. 2011;77:786–94. https://doi.org/10.1055/s-0030-1250599.

Article  CAS  PubMed  Google Scholar 

Zhang Z, Shi L. Anti-inflammatory and analgesic properties of cis-mulberroside A from Ramulus mori. Fitoterapia. 2010;81:214–8. https://doi.org/10.1016/j.fitote.2009.09.005.

Article  CAS  PubMed  Google Scholar 

Lu R, Wei Z, Wang Z, Xu S, Sun K, Cheng P, et al. Mulberroside A alleviates osteoarthritis via restoring impaired autophagy and suppressing MAPK/NF-κB/PI3K-AKT-mTOR signaling pathways. iScience. 2023;26:105936. https://doi.org/10.1016/j.isci.2023.105936.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mosley GE, Hoy RC, Nasser P, Kaseta T, Lai A, Evashwick-Rogler TW, et al. Sex differences in rat intervertebral disc structure and function following annular puncture Injury. Spine. 2019;44:1257–69. https://doi.org/10.1097/BRS.0000000000003055.

Article  PubMed  PubMed Central  Google Scholar 

Vergroesen PP, Kingma I, Emanuel KS, Hoogendoorn RJ, Welting TJ, van Royen BJ, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthr Cartil. 2015;23:1057–70. https://doi.org/10.1016/j.joca.2015.03.028.

Article  Google Scholar 

Wu X, Liu Y, Guo X, Zhou W, Wang L, Shi J, et al. Prolactin inhibits the progression of intervertebral disc degeneration through inactivation of the NF-κB pathway in rats. Cell Death Dis. 2018;9:98. https://doi.org/10.1038/s41419-017-0151-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pfirrmann CW, Metzdorf A, Zanetti M, Hodler J, Boos N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine. 2001;26:1873–8. https://doi.org/10.1097/00007632-200109010-00011.

Article  CAS  PubMed  Google Scholar 

Lu R, Xu H, Deng X, Wang Y, He Z, Xu S, et al. Physalin A alleviates intervertebral disc degeneration via anti-inflammatory and anti-fibrotic effects. J Orthop Translat. 2023;39:74–87. https://doi.org/10.1016/j.jot.2023.01.001.

Article  PubMed  PubMed Central  Google Scholar 

Li H, Ooi SQ, Heng CK. The role of NF-кB in SAA-induced peroxisome proliferator-activated receptor γ activation. Atherosclerosis. 2013;227:72–8. https://doi.org/10.1016/j.atherosclerosis.2012.12.007.

Article  CAS  PubMed  Google Scholar 

Nebbaki SS, Mansouri E, Afif FE, Kapoor H, Benderdour M, Duval M, N., et al. Egr-1 contributes to IL-1-mediated down-regulation of peroxisome proliferator-activated receptor γ expression in human osteoarthritic chondrocytes. Arthritis Res Ther. 2012;14:R69. https://doi.org/10.1186/ar3788.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, et al. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc. 2013;2:e000441. https://doi.org/10.1161/JAHA.113.000441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Speca S, Dubuquoy L, Desreumaux P. Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity. J Clin Gastroenterol. 2014;48(Suppl 1):S23–27. https://doi.org/10.1097/MCG.0000000000000253.

Article  CAS  PubMed  Google Scholar 

Sun Z, Liu ZH, Chen YF, Zhang YZ, Wan ZY, Zhang WL, et al. Molecular immunotherapy might shed a light on the treatment strategies for disc degeneration and herniation. Med Hypotheses. 2013;81:477–80. https://doi.org/10.1016/j.mehy.2013.06.014.

Article  CAS  PubMed  Google Scholar 

Wang F, Cai F, Shi R, Wang XH, Wu XT. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthr Cartil. 2016;24:398–408. https://doi.org/10.1016/j.joca.2015.09.019.

Article  CAS  Google Scholar 

Williams RJ, Tryfonidou MA, Snuggs JW, Le Maitre CL. Cell sources proposed for nucleus pulposus regeneration. JOR Spine. 2021;4:e1175. https://doi.org/10.1002/jsp2.1175.